BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20810657)

  • 1. A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).
    Zhang J; Ravichandran KS; Garrison JC
    J Biol Chem; 2010 Nov; 285(45):34839-49. PubMed ID: 20810657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
    Zhang J; Walk SF; Ravichandran KS; Garrison JC
    J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
    Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
    Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
    Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
    Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.
    Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Wu J; Ogden N; MacRury T; Szabo C
    Br J Pharmacol; 2013 Mar; 168(6):1506-18. PubMed ID: 23121445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
    Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
    J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
    An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
    Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB.
    Malbec O; Schmitt C; Bruhns P; Krystal G; Fridman WH; Daëron M
    J Biol Chem; 2001 Aug; 276(32):30381-91. PubMed ID: 11359765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
    Edimo WE; Janssens V; Waelkens E; Erneux C
    Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
    Waddell GL; Drew EE; Rupp HP; Hansen SD
    J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
    Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
    Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: impact on SHIP1/Ig-α interaction.
    Mukherjee O; Weingarten L; Padberg I; Pracht C; Sinha R; Hochdörfer T; Kuppig S; Backofen R; Reth M; Huber M
    Biochim Biophys Acta; 2012 Feb; 1823(2):206-14. PubMed ID: 22182704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHIP1 and Lyn Kinase Negatively Regulate Integrin alpha IIb beta 3 signaling in platelets.
    Maxwell MJ; Yuan Y; Anderson KE; Hibbs ML; Salem HH; Jackson SP
    J Biol Chem; 2004 Jul; 279(31):32196-204. PubMed ID: 15166241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth.
    Séverin S; Gratacap MP; Lenain N; Alvarez L; Hollande E; Penninger JM; Gachet C; Plantavid M; Payrastre B
    J Clin Invest; 2007 Apr; 117(4):944-52. PubMed ID: 17347685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
    Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
    Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils.
    Vaillancourt M; Levasseur S; Tremblay ML; Marois L; Rollet-Labelle E; Naccache PH
    Cell Signal; 2006 Nov; 18(11):2022-32. PubMed ID: 16682172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
    Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
    Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ENU-induced mouse mutant of SHIP1 reveals a critical role of the stem cell isoform for suppression of macrophage activation.
    Nguyen NY; Maxwell MJ; Ooms LM; Davies EM; Hilton AA; Collinge JE; Hilton DJ; Kile BT; Mitchell CA; Hibbs ML; Jane SM; Curtis DJ
    Blood; 2011 May; 117(20):5362-71. PubMed ID: 21421839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
    Bruyns C; Pesesse X; Moreau C; Blero D; Erneux C
    Biol Chem; 1999; 380(7-8):969-74. PubMed ID: 10494849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol phosphatase SHIP1 is a primary target of miR-155.
    O'Connell RM; Chaudhuri AA; Rao DS; Baltimore D
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7113-8. PubMed ID: 19359473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.